Published in Crit Care Med on September 01, 2013
Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis: A Propensity-Matched Cohort Study. Chest (2016) 1.46
Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med (2016) 1.05
β2-agonists and acute respiratory distress syndrome. Am J Respir Crit Care Med (2014) 0.83
Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock. Crit Care (2016) 0.83
To beta block or not to beta block; that is the question. Crit Care (2015) 0.79
Clinical Effect of Shenfu Injection in Patients with Septic Shock: A Meta-Analysis and Systematic Review. Evid Based Complement Alternat Med (2015) 0.79
Is It Time to Beta Block the Septic Patient? Biomed Res Int (2015) 0.79
Systematic review of use of β-blockers in sepsis. J Anaesthesiol Clin Pharmacol (2015) 0.78
Effects of selective β1-adrenoceptor blockade on cardiovascular and renal function and circulating cytokines in ovine hyperdynamic sepsis. Crit Care (2014) 0.76
The Effect of Esmolol on Tissue Perfusion and Clinical Prognosis of Patients with Severe Sepsis: A Prospective Cohort Study. Biomed Res Int (2016) 0.75
Decatecholaminisation during sepsis. Crit Care (2016) 0.75
Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery*: A Prospective Substudy of a Randomized Controlled Trial. Medicine (Baltimore) (2015) 0.75
β-blockers in septic shock: are we there yet? Rev Bras Ter Intensiva (2017) 0.75
Vasoactive agents for the treatment of sepsis. Ann Transl Med (2016) 0.75
Beta-1 blockade in sepsis: what to expect? Crit Care Med (2013) 0.75
Effects of Safflower Yellow on the Treatment of Severe Sepsis and Septic Shock: A Randomized Controlled Clinical Trial. Evid Based Complement Alternat Med (2016) 0.75
Should β-blockers be used in septic shock? Crit Care (2014) 0.75
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Trial of early, goal-directed resuscitation for septic shock. N Engl J Med (2015) 8.24
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA (2013) 7.23
Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA (2009) 6.55
Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet (2005) 6.33
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet (2005) 5.01
Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med (2013) 4.43
Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet (2002) 4.42
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J (2009) 3.52
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50
Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation (2004) 3.44
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med (2014) 3.37
State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail (2008) 3.35
The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med (2009) 3.30
Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score. Intensive Care Med (2012) 3.24
Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med (2007) 2.79
Statin use and mortality in the bacteremic critically ill patient. Crit Care Med (2006) 2.57
Year in review in Intensive Care Medicine 2011: III. ARDS and ECMO, weaning, mechanical ventilation, noninvasive ventilation, pediatrics and miscellanea. Intensive Care Med (2012) 2.52
Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med (2010) 2.48
Klebsiella pneumoniae ST258 producing KPC-3 identified in italy carries novel plasmids and OmpK36/OmpK35 porin variants. Antimicrob Agents Chemother (2012) 2.46
The Pancreatitis Outcome Prediction (POP) Score: a new prognostic index for patients with severe acute pancreatitis. Crit Care Med (2007) 2.45
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol (2005) 2.45
Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest (2007) 2.38
Rapid Diagnosis of Infection in the Critically Ill, a Multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections. Crit Care Med (2015) 2.37
Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients. Intensive Care Med (2012) 2.33
Mechanisms of sepsis-induced organ dysfunction. Crit Care Med (2007) 2.30
The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals. Crit Care Med (2011) 2.23
Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Crit Care Med (2010) 2.22
Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2013) 2.18
Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med (2010) 2.17
High incidence of myocardial ischemia during postpartum hemorrhage. Anesthesiology (2004) 2.16
Perioperative use of levosimendan: best practice in operative settings. J Cardiothorac Vasc Anesth (2012) 2.15
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. Am Heart J (2013) 2.09
The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. Liver Int (2014) 2.07
Medication errors: a prospective cohort study of hand-written and computerised physician order entry in the intensive care unit. Crit Care (2005) 2.03
Echocardiography in the ICU: time for widespread use! Intensive Care Med (2005) 2.03
Understanding the benefits and harms of oxygen therapy. Intensive Care Med (2015) 2.00
Terlipressin for norepinephrine-resistant septic shock. Lancet (2002) 1.99
Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med (2009) 1.99
Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol (2003) 1.95
Propensity scores in intensive care and anaesthesiology literature: a systematic review. Intensive Care Med (2010) 1.89
Measurement of H2O2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell Metab (2011) 1.87
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med (2005) 1.83
The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth (2004) 1.80
Volatile agents for cardiac protection in noncardiac surgery: a randomized controlled study. J Cardiothorac Vasc Anesth (2011) 1.79
Medical emergency team and non-invasive ventilation outside ICU for acute respiratory failure. Intensive Care Med (2008) 1.78
A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc (2013) 1.77
Variability in management of early severe sepsis. Emerg Med J (2010) 1.76
Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. J Am Coll Cardiol (2009) 1.76
Tracking changes in cardiac output: methodological considerations for the validation of monitoring devices. Intensive Care Med (2009) 1.76
Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages. Am J Physiol Regul Integr Comp Physiol (2004) 1.74
Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med (2007) 1.74
H1N1 pneumonitis treated with intravenous zanamivir. Lancet (2009) 1.73
Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J (2012) 1.70
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol (2013) 1.69
Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med (2005) 1.69
Continuous monitoring of cerebral oxygen saturation in elderly patients undergoing major abdominal surgery minimizes brain exposure to potential hypoxia. Anesth Analg (2005) 1.69
Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: results from a short and mid-term study. Eur J Heart Fail (2008) 1.68
Role of selective V1a receptor agonism in ovine septic shock. Crit Care Med (2011) 1.68
Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis. Crit Care Med (2007) 1.68
Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art? Crit Care Med (2005) 1.65
Epidural analgesia improves outcome in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth (2009) 1.65
International study on microcirculatory shock occurrence in acutely ill patients. Crit Care Med (2015) 1.64
Potential metabolic consequences of statins in sepsis. Crit Care Med (2011) 1.64
Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol (2010) 1.63
Clinical review: Update on hemodynamic monitoring--a consensus of 16. Crit Care (2011) 1.62
Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis. Eur J Heart Fail (2011) 1.60
Use of the laryngeal mask airway and a modified sequential intubation technique for the management of an unanticipated difficult airway in a remote location. Can J Anaesth (2003) 1.60
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study. Crit Care (2013) 1.60
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia. Intern Emerg Med (2011) 1.59
Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med (2008) 1.59
Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med (2002) 1.59
Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med (2003) 1.59
Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med (2007) 1.58
Methylene blue as a vasopressor: a meta-analysis of randomised trials. Crit Care Resusc (2013) 1.58
Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth (2007) 1.58
Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality. Int J Cardiol (2011) 1.57